Ads
related to: gsk and pfizer joint venture- Corporate Growth Strategy
EY-Parthenon
Strategy Consulting Services
- Corporate Finance
Learn What EY Can Do For Your
Corporate Finance Strategy.
- Buy & Integrate
How Our M&A Advisory Team Can
Help Enable Strategic Growth.
- Strategy Services
EY-Parthenon
From Strategy to Execution
- Corporate Growth Strategy
Search results
Results From The WOW.Com Content Network
The company was created as a joint venture by GSK and Pfizer in November 2009, with both companies transferring their HIV assets to the new company. [1] In 2012, Shionogi joined the company. As of December 2023, 76.5% of the company is owned by GSK, 13.5% by Pfizer and 10% by Shionogi. [2]
Also in November 2009, GSK formed a joint venture with Pfizer to create ViiV Healthcare, which specializes in HIV research. [49] In 2010, the company acquired Laboratorios Phoenix, an Argentine pharmaceutical company, for US$253m, [50] and the UK-based sports nutrition company Maxinutrition for £162 million (US$256 million). [51]
GSK and Pfizer merged their consumer healthcare businesses in 2019. [8] [9] GSK owned just over two thirds of the joint venture, and Pfizer held the remainder.[8]GSK announced plans to spin off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division".
On Saturday Unilever confirmed its interest in purchasing the division, a joint venture between GSK and Pfizer which owns brands including Sensodyne toothpaste, Centrum multivitamins and Advil ...
In a first, a monthly injectable HIV drug made by a GlaxoSmithKline plc (NYSE: GSK)- and Pfizer Inc (NYSE: PFE)-owned company has received the approval of the United States Food and Drug ...
Glaxo (GSK) and Pfizer (PFE) agree to merge their consumer healthcare units into a new JV. J&J stock hit by reports alleging it of being aware of the presence of asbestos in baby powder.
LONDON (Reuters) -Pfizer plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK, after the business lists as an independent company in July, GSK said on ...
GSK sold around 385 million shares at 324 pence apiece, amounting to a 4.2% stake in Haleon. The company was formed in a merger of GSK and Pfizer's consumer healthcare businesses in 2019. The sale ...